Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Polypill Treatment Offers High Value in Low-Income, Underserved Population

Polypill treatment for cardiovascular disease prevention is of high value in a low-income, underserved population, according to a study published online Jan. 8

Adding Depression, Anxiety Measures to CVD Prediction Model Has Little Impact

Inclusion of measures of depression and anxiety to the American Heart Association Predicting Risk of Cardiovascular Disease Events (PREVENT) prediction model ha

Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms

For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcom

Link Between Gum Disease, Brain Function Exists, Small Study Says

Gum disease appears to disrupt brain activity, potentially increasing a person s risk of cognitive decline. People with gum disease experienced altered connecti

Fecal Transplants May Help People Who Have Diabetes, Gut Issues, Study Says

A fecal transplant could help people whose type 1 diabetes has fouled up their digestive system. Swallowing a handful of capsules filled with donor feces helped

What Do Sleep Medications Do to Your Brain?

The sleep aid Ambien could be allowing toxic proteins to pollute the brain, potentially increasing a person s risk of disorders like Alzheimer s disease. Drugs

Neglect Can Be as Damaging to Child Development as Abuse, in Some Ways

Simple neglect can be as damaging to a child s social development as physical, sexual or emotional abuse. Children whose basic needs aren t met can have lifelon

Multiple Violations Found At McDonald's Onion Supplier After Deadly E.Coli Outbreak

U.S. Food and Drug Administration (FDA) officials have uncovered dozens of violations at a McDonald s supplier tied to last year s deadly E.coli outbreak, which

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

Mersana Therapeutics, Inc. (NASDAQ MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugate

Nipocalimab Granted U.S. FDA Priority Review for the Treatment of Generalized Myasthenia Gravis

SPRING HOUSE, Pa., (January 9, 2025) Johnson Johnson (NYSE JNJ) today announced the nipocalimab Biologics License Application (BLA) received Priority Review des

Popular Keywords